Clinical Trials
11
Active:0
Completed:7
Trial Phases
3 Phases
Phase 3:1
Phase 4:3
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (42.9%)Phase 4
3 (42.9%)Phase 3
1 (14.3%)Intravenous Dexmedetomidine for Emergence Delirium in Pediatric Patient
Phase 4
Recruiting
- Conditions
- DexmeditomidineEmergence Delirium
- Interventions
- Drug: normal saline
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Security Forces Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05813106
- Locations
- 🇸🇦
Security Forces Hospital, Riyadh, Saudi Arabia
Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries
Phase 4
Recruiting
- Conditions
- Postoperative Pain
- Interventions
- Other: ESPB (regional Block)
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Security Forces Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT05664542
- Locations
- 🇸🇦
Security Forces Hospital, Riyadh, Saudi Arabia
Dexmedetomidine in Reducing Incidence of Emergence Agitation After Nasal Surgery
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Security Forces Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT05634148
- Locations
- 🇸🇦
Security Forces Hospital, Riyadh, Saudi Arabia
Ultrasound-guided Erector Spinae Plane Block Using Catheter for Video-assisted Thoracoscopy
Not Applicable
- Conditions
- Opioid UsePost Operative Pain
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Security Forces Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT05337956
- Locations
- 🇸🇦
Security Forces Hospital Program, Riyadh, Saudi Arabia
Role of Preoperative Transdermal Buprenorphine Patch in Reducing Postoperative Opioids Consumption in Patients Undergoing Total Knee Arthroplasties - A Randomised Controlled Trial.
Phase 4
Recruiting
- Conditions
- Patients Aged Between 18 and 65years Undergoing Total Knee Arthroplasty
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Security Forces Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05042648
- Locations
- 🇸🇦
Security Forces Hospital Program, Riyadh, Saudi Arabia
- Prev
- 1
- 2
- 3
- Next
News
No news found